DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Testolactone

Testolactone

  • (12) United States Patent (10) Patent No.: US 6,284,263 B1 Place (45) Date of Patent: Sep

    (12) United States Patent (10) Patent No.: US 6,284,263 B1 Place (45) Date of Patent: Sep

  • Pharmaceutical Appendix to the Tariff Schedule 2

    Pharmaceutical Appendix to the Tariff Schedule 2

  • Medication Use for the Risk Reduction of Primary Breast Cancer in Women: a Systematic Review for the U.S

    Medication Use for the Risk Reduction of Primary Breast Cancer in Women: a Systematic Review for the U.S

  • Controlled Substances Listed in This Section from Schedule VI

    Controlled Substances Listed in This Section from Schedule VI

  • TESLAC (Testolactone Tablets, USP) Is Available for Oral Administration As Tablets Providing 50 Mg Testolactone Per Tablet

    TESLAC (Testolactone Tablets, USP) Is Available for Oral Administration As Tablets Providing 50 Mg Testolactone Per Tablet

  • AHFS Therapeutic

    AHFS Therapeutic

  • Testotoxicosis: Gonadotrophin - Independent Male Sexual Precocity

    Testotoxicosis: Gonadotrophin - Independent Male Sexual Precocity

  • Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös

    Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Aromatase Inhibitors in the Treatment of Oligozoospermic Or Azoospermic Men: a Systematic Review of Randomized Controlled Trials

    Aromatase Inhibitors in the Treatment of Oligozoospermic Or Azoospermic Men: a Systematic Review of Randomized Controlled Trials

  • SENATE BILL No. 1237 No

    SENATE BILL No. 1237 No

  • 2019 Prohibited List

    2019 Prohibited List

  • (12) Patent Application Publication (10) Pub. No.: US 2003/0198664 A1 Sullivan Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2003/0198664 A1 Sullivan Et Al

  • Cancer Drug Costs for a Month of Treatment at Initial Food

    Cancer Drug Costs for a Month of Treatment at Initial Food

  • Recent Advances in the Analysis of Steroid Hormones and Related Drugs

    Recent Advances in the Analysis of Steroid Hormones and Related Drugs

  • NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

    NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

  • 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs

    2012 NIOSH List of Antineoplastic and Other Hazardous Drugs

  • BCBSNM/HMONM Therapeutic Class Drug List (Formulary) 2004

    BCBSNM/HMONM Therapeutic Class Drug List (Formulary) 2004

Top View
  • Letrozole Once a Week Normalizes Serum Testosterone in Obesity-Related Male Hypogonadism
  • Reproductive Health Guideline Appendix 3 – Search Strategies
  • Prohibited List 2021
  • Council of Europe Committee of Ministers (Partial
  • Theoretical Investigations on the Role of Steroid-Skeleton C4= C5
  • Rational Management of Endocrine Resistance in Breast Cancer a Comprehensive Review of Estrogen Receptor Biology, Treatment Options, and Future Directions
  • Aromatase Destabilizer: Novel Action of Exemestane, a Food and Drug Administration–Approved Aromatase Inhibitor
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Banned Substances
  • Examples of Prohibited and Permitted Substances And
  • Drug-Induced Hyperandrogenism 121 10 Drug-Induced Hyperandrogenism
  • 2019 Equine Prohibited Substances List
  • Rules of Department of Health and Senior Services Division 30—Division of Regulation and Licensure Chapter 1—Controlled Substances
  • Oklahoma Drug Statutes (Listed in Numerical Order)
  • Treatment of Testosterone-Induced Gynecomastia with the Aromatase Inhibitor, Anastrozole
  • Customs Tariff - Schedule Xxi - 1
  • Specialty Drug List 08-24-10
  • Review of the Role of Spironolactone in the Therapy of Children


© 2024 Docslib.org    Feedback